London, 18 February 2015: TechNavio, the independent tech-focused global research firm, has published a report on the Global POC Diagnostics Market 2015-2019, which is expected to post a CAGR of 8.47 percent during the forecast period of 2014-2019.
“Portable POC diagnostics are comparatively inexpensive, more hygienic, and much more efficient than fixed POC diagnostics,” says Faisal Ghaus, Vice President of TechNavio.
“Advances in technology have aided manufacturers in developing new innovative portable products with licenses for single-owner use.”
Key Market Drivers
- High Prevalence of Diabetes and Obesity
- Advances in Technology
- Growing Elderly Population
- Increased Expenditure on Healthcare
Key Market Trends
- Rapid Adoption of POC Diagnostic Tests
- Growing Focus on Developing Countries
- Popularity of Portable POCT Products
- Increase in M&A
Key Market Vendors
- Abbott Laboratories Inc.
- Alere Inc.
- Bayer Healthcare
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
